Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coady Diemar Partners was a boutique investment banking firm that provided strategic advisory and capital raising services to growth-stage and middle-market companies. The firm maintained a specialized focus on the healthcare, technology, and digital media sectors, offering expertise in mergers and acquisitions, private placements, and strategic partnerships. In June 2021, the firm was acquired by Peapack-Gladstone Financial Corporation to serve as the foundation for its new investment banking division, Peapack Private. During its independent operation, Coady Diemar was recognized for its high-touch, partner-led approach to complex financial transactions. The firm's leadership, including founders Colin Coady and Robert Diemar, transitioned to Peapack-Gladstone to continue their advisory work within the larger financial institution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coady Diemar Partners.